A Phase I study of the novel immunomodulatory agent PG545 (pixatimod) in subjects with advanced solid tumours.
about
A Phase I study of the novel immunomodulatory agent PG545 (pixatimod) in subjects with advanced solid tumours.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
A Phase I study of the novel i ...... s with advanced solid tumours.
@en
A Phase I study of the novel immunomodulatory agent PG545
@nl
type
label
A Phase I study of the novel i ...... s with advanced solid tumours.
@en
A Phase I study of the novel immunomodulatory agent PG545
@nl
prefLabel
A Phase I study of the novel i ...... s with advanced solid tumours.
@en
A Phase I study of the novel immunomodulatory agent PG545
@nl
P2093
P2860
P1476
A Phase I study of the novel i ...... s with advanced solid tumours.
@en
P2093
Darryn Bampton
Edward Hammond
Fleur Lankesheer
Glynn Morrish
Jason D Lickliter
Keith Dredge
Michael Millward
Michael P Brown
Paul Handley
P2860
P2888
P304
P356
10.1038/S41416-018-0006-0
P407
P577
2018-03-13T00:00:00Z